Skip to main content
Log in

Possible Ways of Studying Pharmacokinetic Parameters of Calcium Preparations

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Issues pertaining to determination of the pharmacokinetic parameters of calcium preparations are examined using their comparative bioavailability as an example. Pharmacokinetic parameters of calcium such as area under the concentration—time curve (AUC) and maximum concentration (Cmax) are calculated considering the background calcium contents in volunteers. Calcium excretion with urine is assessed as clearance of creatinine, a calcium elimination factor. The dynamics of the content of parathormone (PTH), the main hormone regulating calcium homeostasis, are studied. The results can be used to plan clinical trials for assessing the pharmacokinetics of drug analogs of endogenous compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. http://grls.rosminzdrav.ru

  2. L. Fialova and M. Vejrahka, Metabolism of Calcium and Phosphorus, Prague (2010 / 2011).

  3. M. Peacock, Clin. J. Am. Soc. Nephrol., 5, S23 – S30 (2010).

    Article  PubMed  CAS  Google Scholar 

  4. Human Vitamin and Mineral Requirements. Report of a Joint FAO / WHO Expert Consultation, World Health Organization, Bangkok, Thailand (2001), p. 303.

  5. E. V. Shikh and A. A. Makhova, Eff. Farmakoter., 36, 24 – 30 (2013).

    Google Scholar 

  6. B. G. Iskanderov, Arterial Hypertension and Calcium Metabolism [in Russian], Penza (2010), p. 225.

  7. A. N. Mironov, Guide to Drug Review [in Russian], Vol. 1, Moscow (2013), p. 323.

  8. Rules of Carrying Out Research of Bioequivalence of Medicines Within the Eurasian Economic Union, approved by a Decision of Council of the Eurasian Economic Commission of Nov. 3, 2016, No. 85, Moscow (2016).

  9. Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA, United States Food and Drug Administration, New Hampshire (2013).

  10. Investigation of Bioequivalence (CPMP / EWP / QWP / 1401 / 98 Rev. 1), European Medicines Agency, London (2013).

  11. P. Colucci, M. Pasternyk-Di Marco, D. Potvin, et al., Generic Drug Product Development: Bioequivalence Issues, Boca Raton (2007), pp. 233 – 256.

  12. S. Dissanayake, Br. J. Clin. Pharmacol., 69(3), 238 – 244 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. J. Gabrielsson and D. Weiner, Am. J. Pharm. Educ., 74(3), 1250 (2010).

    Google Scholar 

  14. N. N. Eremenko, D. V. Goryachev, and E. V. Shikh, Vedom. Nauchn. Tsentra Eksp. Sredstv Med. Primen., 7(2), 104 – 110 (2017).

    Google Scholar 

  15. A. Marzo, Ital. J. Med., 7(3), 156 – 159 (2013).

    Article  CAS  Google Scholar 

  16. A. Marzo, Pharmacol. Res., No. 40, 357 – 368 (1999).

  17. G. Kressel, M. Wolters, and A. Hahn, Food Nutr. Sci., 1, 53 – 58 (2010).

    CAS  Google Scholar 

  18. N. N. Eremenko, E. V. Shikh, and S. Yu. Serebrova, Patogenez, 14(4), 69 – 73 (2016).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. N. Eremenko.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 3, pp. 7 – 9, March, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eremenko, N.N., Shikh, E.V., Serebrova, S.Y. et al. Possible Ways of Studying Pharmacokinetic Parameters of Calcium Preparations. Pharm Chem J 52, 195–197 (2018). https://doi.org/10.1007/s11094-018-1789-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1789-2

Keywords

Navigation